Related Experiment Video
Updated: Aug 4, 2026

11:36
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Flutamide-induced hepatotoxicity: ethical and scientific issues
R Giorgetti1, M di Muzio, A Giorgetti
1Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy. r.giorgetti@univpm.it.
European Review for Medical and Pharmacological Sciences
|April 6, 2017
Summary
Flutamide (FLU), used off-label for women
Area of Science:
- Pharmacology
- Hepatology
- Reproductive Medicine
Background:
- Flutamide (FLU) is a non-steroidal antiandrogen approved for advanced prostate cancer.
- It is frequently prescribed off-label for women with polycystic ovary syndrome (PCOS)-related hirsutism and acne.
- Adverse event incidence may be higher in women than in men.
Purpose of the Study:
- To investigate the adverse effects of Flutamide (FLU) on hepatic and reproductive function in women.
- To review the scientific literature on Flutamide's (FLU) safety profile in female patients.
- To assess the ethical and legal implications of off-label Flutamide (FLU) use in women.
Main Methods:
- A comprehensive literature search was performed in major scientific databases.
- Studies focused on unintended Flutamide (FLU) effects on liver and reproductive health.
- Both human and animal studies were included, with reference lists of selected papers also reviewed.
Main Results:
- Twenty-three human studies (case reports, retrospective, prospective, surveillance, observational) were analyzed.
- Nine animal studies were also evaluated.
- Evidence indicates Flutamide (FLU) is associated with specific hepatotoxic profiles in females.
Conclusions:
- Flutamide (FLU) poses risks for hepatotoxicity in women.
- Off-label prescription of Flutamide (FLU) for women is ethically questionable and potentially unlawful.
- Prescribers may face liability without adequate safeguards for off-label Flutamide (FLU) use in female patients.
Related Concept Videos
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

